Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

Clinical trial NCT00558272 · COMPLETED

Trial details

NCT number: NCT00558272
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Prostate Cancer Bone Neoplasms

Start date: 2008-02-01
Primary completion: 2010-01-01
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.